… It was shown that curcumin exhibits anti-cancer effect in several tumour models through
regulating PI3K/Akt/mTOR pathway whereby it suppresses the Akt activation along with …

… As mentioned above, EGCG is recognized to have the strongest anti-cancer activity among
… positive PC cells in the prostate tissues of a xenograft model injected with androgen-sensitive …

… modeling of these compounds was studied on human methionine aminopeptidase-2. All
synthesized compounds were screened for anticancer activity against three prostate cancer cell …

… In a prostate cancer xenograft mouse model, the volume and weight of solid tumors were
markedly reduced on luteolin (10 mg/kg/day) treatment, clearly showing that luteolin restrains …

… Rodent models had shown that statins induced an antitumor effect through the reduction of
… and radiotherapy enhanced the reduction of prostate tumor growth in mouse models [19]. MF …

… a niche unsuitable for tumor-infiltrating immune cells with antitumor activities, leading to …
results indicate promising outcome with murine prostate cancer model (109). Conventional …

… Various preclinical models have been developed to clarify the pathophysiology of prostate
cancer (… , and a PI3K/mTOR inhibitor exerts a significant antitumor effect on the PC3CR cells. …

… agent for prostate cancer. Definitive evidence to support the anticancer effect of lycopene is
… prostate cancer tumor models would greatly facilitate the clinical translation of lycopene in …

… ), which enhanced T and NK anti-tumor activity in a preclinical mouse model (76). A
Phase I trial recruiting patients with locally recurrent prostate cancer for Ad5-yCD/mutTKSR39rep-…

… tumor types. The compounds showed promising anticancer activity in different tumor models
[… This analysis showed that C6 was more potent in the prostate tumor cells (IC 50 = 0.6 μM) …